BP000425-HSV-222: Recombinant HSV-2 gD
Source: E. coli-derived.
Specificity: Immunoreactive with sera of HSV-infected individuals.
Purity>95.0% by 10% PAGE.
Applications: WB, ELISA.BP000425-HSV-220: HSV-2 gG
Specificity: Immunoreactive with sera of HSV-infected individuals.
Purity>99.0% by Analytical HPLC and Mass Spec.
Applications: WB, ELISA.BP000425-HSV-223: Recombinant HSV-2 gG
Source: E. coli-derived.
Specificity: Immunoreactive with sera of HSV-infected individuals.
Purity>95.0% by 10% PAGE.
Applications: WB, ELISA.BP000424-HSV-224: Recombinant HSV-1 gG
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Applications: WB, ELISA.BP000424-HSV-221: Recombinant HSV-1 gD
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Applications: WB, ELISA.BP000444-HIV-151: Recombinant HIV-2 gp36, MBP Tag
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000444-HIV-139: Recombinant HIV-2 gp36 (390-702 a.a.)
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000444-HIV-152: Recombinant HIV-2 gp36, His Tag
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISABP000444-HIV-138: Recombinant HIV-2 gp36
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000443-HIV-134: Recombinant HIV-2 gp32
Source: E. coli-derived.
Specificity: Immunoreactive with all sera of HIV-2 infected individuals.
Purity > 95%, by SDS-PAGE.
Applications: WB, ELISA.